Bal Pharma reports around 4-fold jump in Q1 consolidated net profit

11 Aug 2021 Evaluate

Bal Pharma has reported results for first quarter ended June 30, 2021.

The company has reported 30.93% rise in its net profit at Rs 2.15 crore for the quarter under review as compared to net profit of Rs 1.64 crore for the same quarter in the previous year. Total income of the company increased by 35.40% at Rs 71.14 crore for Q1FY22 as compared Rs 52.54 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported around 4-fold jump in its net profit attributable to equity holdars of the parent company at Rs 1.62 crore for the quarter under review as compared to net profit of Rs 0.42 crore for the same quarter in the previous year. Total income of the company increased by 35.72% at Rs 70.96 crore for Q1FY22 as compared Rs 52.29 crore for the corresponding quarter previous year. 

Bal Pharma Share Price

71.75 -2.82 (-3.78%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×